CN105213941A - 一种用于治疗小儿腹泻的中药组合物及其制备方法 - Google Patents
一种用于治疗小儿腹泻的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105213941A CN105213941A CN201510719192.6A CN201510719192A CN105213941A CN 105213941 A CN105213941 A CN 105213941A CN 201510719192 A CN201510719192 A CN 201510719192A CN 105213941 A CN105213941 A CN 105213941A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- herba
- radix
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 114
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 238000011282 treatment Methods 0.000 title claims abstract description 54
- 208000019637 Infantile Diarrhea Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241001116389 Aloe Species 0.000 claims abstract description 31
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 31
- 241000628997 Flos Species 0.000 claims abstract description 26
- 241000746375 Andrographis Species 0.000 claims abstract description 25
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 25
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 241000005787 Cistanche Species 0.000 claims abstract description 24
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 15
- 239000012567 medical material Substances 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 206010012735 Diarrhoea Diseases 0.000 description 57
- 230000000694 effects Effects 0.000 description 35
- 210000000952 spleen Anatomy 0.000 description 33
- 210000002784 stomach Anatomy 0.000 description 27
- 208000002193 Pain Diseases 0.000 description 26
- 239000008280 blood Substances 0.000 description 25
- 230000036407 pain Effects 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 23
- 210000003734 kidney Anatomy 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 201000010099 disease Diseases 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 206010047700 Vomiting Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 208000001848 dysentery Diseases 0.000 description 10
- 230000008673 vomiting Effects 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000003014 reinforcing effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 201000006549 dyspepsia Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 206010000077 Abdominal mass Diseases 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010043458 Thirst Diseases 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 208000019902 chronic diarrheal disease Diseases 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 208000004232 Enteritis Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010060891 General symptom Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 150000004056 anthraquinones Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 229940097275 indigo Drugs 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010011469 Crying Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 2
- 241000334154 Isatis tinctoria Species 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241001529246 Platymiscium Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- -1 daiazi Chemical compound 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000026775 severe diarrhea Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- VWEWSCDQMVNOJP-UHFFFAOYSA-N 4', 7-Di-O-beta-D-glucopyranoside-4', 7-Dihydroxyisoflavone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2C(C3=CC=C(OC4C(C(O)C(O)C(CO)O4)O)C=C3OC=2)=O)C=C1 VWEWSCDQMVNOJP-UHFFFAOYSA-N 0.000 description 1
- OOXNYFKPOPJIOT-UHFFFAOYSA-N 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C=12C(N)=NC=NC2=NC(C=2C=NC(=CC=2)N2CCOCC2)=CC=1C1=CC=CC(Br)=C1 OOXNYFKPOPJIOT-UHFFFAOYSA-N 0.000 description 1
- VWEWSCDQMVNOJP-IPOZFMEPSA-N 7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2C(C3=CC=C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C=C3OC=2)=O)C=C1 VWEWSCDQMVNOJP-IPOZFMEPSA-N 0.000 description 1
- UWRLUNPRLSNXRR-PGPONNFDSA-N 7-hydroxy-3-(4-methoxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one Chemical compound C1=CC(OC)=CC=C1C(C(C1=CC=C2O)=O)=COC1=C2[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 UWRLUNPRLSNXRR-PGPONNFDSA-N 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 108010076278 Adenosine kinase Proteins 0.000 description 1
- 102100032534 Adenosine kinase Human genes 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000128850 Spirometra folium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- NAHTXVIXCMUDLF-DUJPAFNYSA-N Toosendanin Natural products O=C(O[C@H]1C(=O)[C@H]2[C@@](C)([C@H](O)C[C@H]3[C@@]4(C)[C@H](O)OC[C@@]23[C@@H](O)C[C@H]4OC(=O)C)[C@@]23[C@]1(C)[C@H](c1cocc1)C[C@H]2O3)C NAHTXVIXCMUDLF-DUJPAFNYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- NAHTXVIXCMUDLF-RFNFAWMESA-N toosendanin Chemical compound C=1([C@H]2[C@]3(C)[C@@H](OC(C)=O)C(=O)[C@H]4[C@@]([C@@]53O[C@@H]5C2)(C)[C@H](O)C[C@H]2[C@@]3(C)[C@H](O)OC[C@]24[C@@H](O)C[C@H]3OC(=O)C)C=COC=1 NAHTXVIXCMUDLF-RFNFAWMESA-N 0.000 description 1
- 239000008488 toosendanin Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于治疗小儿腹泻的中药组合物,由艾叶、乌药、吴茱萸、穿心莲、石斛、山药、豆蔻、知母、葛根、金银花、青黛、藿香、桂枝、荷叶、王不留行、木通、徐长卿、川楝子、芦荟、仙鹤草、巴戟天、肉苁蓉、佛手、荜拨、陈皮、厚朴、马齿苋、合欢皮、三七、地榆、桑葚等原料药组成。该中药组合物配制简便,药源广泛,成本低廉,其遵循中医的处方用药原则,诸药合用,相得益彰,治疗小儿腹泻方面疗效显著。
Description
技术领域
本发明属于医药技术领域,涉及一种中药组合物,具体涉及一种用于治疗小儿腹泻的中药组合物及其制备方法。
背景技术
腹泻就是俗称的“拉肚子”,它的症状是大便次数、数量增多,粪质稀薄或如水样。本病多见于2岁以内婴幼儿,年龄愈小,发病率愈高。感染细菌和病毒都可以引起腹泻,受凉或饮食不当也会引起泄泻,本病一年四季均可发生,尤其以夏秋季节为多见。腹泻轻症一般预后良好,重症腹泻、重症佝偻病、营养不良的小儿合并腹泻则预后较差,并有一定的病死率。腹泻中医称为泄泻,包括了西医所称的各种细菌、病毒而致的肠炎及消化不良。
小儿腹泻主要表现为大便次数增多及大便性质变稀,常伴呕吐、发热,严重者可引起脱水、电解质紊乱及酸中毒。轻症腹泻,一般每日便次在10次以内,精神尚可,能进食,少呕恶;重症者,暴泻便次达10余次或几十次,病程迁延不愈,小便短少,甚至无尿,或四肢不温,大便清冷。
中医根据导致小儿腹泻的不同病因,将泄泻分为多种类型:伤食泻是指小儿肚子胀满疼痛,腹痛时想大便,腹泻后疼痛减轻,大便酸臭或如臭鸡蛋气味,夹有食物残渣或乳块,嗳腐呕吐,不想吃饭,甚至拒食,矢气臭秽,夜间睡眠时翻滚不安。因受寒凉而引起的风寒泻,可以见到大便清稀,泡沫多,气味不显著,大便颜色淡黄,可以听到肚子咕噜咕噜响,并伴有疼痛,有的小儿还兼有恶寒发热,或鼻塞、肢体酸痛。夏天感染细菌所致的泄泻往往是湿热泻,腹泻来势急迫,大便稀薄,像水样,颜色深黄,气味臭,或夹粘液,肛门灼热,腹痛阵哭,食欲不振,或发热烦闹,口渴喜饮,小便黄少。秋冬季节感染病毒时,大便往往清稀或溏薄不成形,泻下清冷或完谷不化,腹痛喜暖,手足不温,不发热,这是风寒证;部分小儿体质比较弱,泄泻病程迁延,时轻时重或时发时止,大便稀薄,色淡不臭,夹有不消化乳食,食后欲泻,多食多泻,食欲不振,面色萎黄,神疲倦怠,形体消瘦,属中医的脾虚泻。如果久泻不止,食入即泻,粪质清稀,完谷不化,或见脱肛,形寒肢冷,面色淡白,精神委靡,睡时露睛,是脾肾阳虚泻。重症泄泻的小儿见到泻下无度,质稀如水,小便短少,皮肤干燥或枯瘪,目眶及囟门凹陷,啼哭无泪,精神委靡或虚烦不宁,口渴引饮,齿干唇红,是伤阴泻。而久泻或暴泻不止,便稀如水,面色苍白或青灰,神怯气弱,表情淡漠,四肢厥冷,肤出冷汗,则是伤阳泻。
现在临床上治疗小儿腹泻的药物较多,有中成药和西药,但他们对小儿腹泻治疗效果有限,不能在很短时间内治疗小儿腹泻,使儿童的身体受到损伤恶化。目前西医采用肠黏膜保护剂、微生态制剂及补锌等疗效确切的治疗方法,但是在抗RV病原药物方面,目前尚无较理想的选择,临床上多采用病毒唑,但其对病毒腺苷激酶依赖性太强,易产生耐药性,且常可因病毒感染及药物双重作用而出现粒细胞缺乏,限制了其用药的时间。西药治疗虽有一定疗效,但在缩短疗程上仍不足。从临床实践来看,西医注重补充液体,虽防脱水效果较好,但止泻作用缓慢。随着中国中医中药学的不断发展,在治疗小儿腹泻上,人们渐渐意识到了中药治疗小儿腹泻副作用小,承受痛苦小的优点,而中医治疗重视整体观念,重视综合治理,重视辨证施治,在治疗效果上更加显示出中药治疗小儿腹泻的优势。中药有调节内分泌、治疗小儿腹泻,改善气血循环,祛咳的特殊功效,而且作用持久、标本兼治、无副作用、并且疗效巩固、不易复发。
发明内容
本发明针对现有技术中的不足之处,提供一种用于治疗小儿腹泻的中药组合物,该中药组合物具有见效快、疗效高、患儿易于接受、无毒副作用、安全方便的特点。
本发明的上述目的是通过下述技术方案来实现的:
一种用于治疗小儿腹泻的中药组合物,所述中药组合物的原料药由艾叶、乌药、吴茱萸、穿心莲、石斛、山药、豆蔻、知母、葛根、金银花、青黛、藿香、桂枝、荷叶、王不留行、木通、徐长卿、川楝子、芦荟、仙鹤草、巴戟天、肉苁蓉、佛手、荜拨、陈皮、厚朴、马齿苋、合欢皮、三七、地榆、桑葚等原料药组成。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶15-20份,乌药10-15份,吴茱萸8-12份,穿心莲2-5份,石斛3-7份,山药11-14份,豆蔻9-15份,知母3-6份,葛根3-6份,金银花8-13份,青黛3-5份,藿香11-15份,桂枝5-10份,荷叶2-5份,王不留行4-9份,木通12-20份,徐长卿10-16份,川楝子3-8份,芦荟5-12份,仙鹤草12-17份,巴戟天7-12份,肉苁蓉4-9份,佛手8-13份,荜拨3-5份,陈皮1-3份,厚朴5-10份,马齿苋5-10份,合欢皮13-16份,三七3-10份,地榆8-13份,桑葚3-5份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶15份,乌药15份,吴茱萸8份,穿心莲5份,石斛3份,山药14份,豆蔻9份,知母6份,葛根6份,金银花8份,青黛3份,藿香15份,桂枝5份,荷叶3份,王不留行5份,木通12份,徐长卿16份,川楝子3份,芦荟12份,仙鹤草12份,巴戟天10份,肉苁蓉9份,佛手8份,荜拨5份,陈皮1份,厚朴10份,马齿苋5份,合欢皮16份,三七10份,地榆8份,桑葚5份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶20份,乌药10份,吴茱萸12份,穿心莲2份,石斛7份,山药11份,豆蔻15份,知母3份,葛根4份,金银花10份,青黛4份,藿香13份,桂枝6份,荷叶4份,王不留行8份,木通20份,徐长卿10份,川楝子8份,芦荟5份,仙鹤草17份,巴戟天12份,肉苁蓉4份,佛手13份,荜拨3份,陈皮3份,厚朴5份,马齿苋10份,合欢皮13份,三七3份,地榆13份,桑葚3份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶18份,乌药11份,吴茱萸9份,穿心莲4份,石斛6份,山药12份,豆蔻13份,知母4份,葛根5份,金银花12份,青黛3份,藿香12份,桂枝9份,荷叶4份,王不留行7份,木通13份,徐长卿11份,川楝子4份,芦荟6份,仙鹤草13份,巴戟天7份,肉苁蓉5份,佛手9份,荜拨4份,陈皮2份,厚朴6份,马齿苋6份,合欢皮14份,三七5份,地榆10份,桑葚4份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶16份,乌药14份,吴茱萸11份,穿心莲3份,石斛5份,山药13份,豆蔻14份,知母5份,葛根4份,金银花11份,青黛4份,藿香14份,桂枝8份,荷叶3份,王不留行6份,木通17份,徐长卿15份,川楝子7份,芦荟11份,仙鹤草16份,巴戟天8份,肉苁蓉8份,佛手12份,荜拨3份,陈皮1份,厚朴10份,马齿苋9份,合欢皮13份,三七7份,地榆11份,桑葚3份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶19份,乌药13份,吴茱萸10份,穿心莲4份,石斛4份,山药11份,豆蔻11份,知母5份,葛根6份,金银花9份,青黛5份,藿香12份,桂枝7份,荷叶5份,王不留行9份,木通15份,徐长卿12份,川楝子5份,芦荟9份,仙鹤草15份,巴戟天9份,肉苁蓉7份,佛手10份,荜拨5份,陈皮3份,厚朴8份,马齿苋8份,合欢皮14份,三七9份,地榆12份,桑葚5份。
进一步地,制成所述中药组合物的原料组成及重量份数为:艾叶17份,乌药13份,吴茱萸10份,穿心莲4份,石斛4份,山药11份,豆蔻11份,知母5份,葛根3份,金银花8份,青黛5份,藿香15份,桂枝7份,荷叶2份,王不留行4份,木通19份,徐长卿14份,川楝子6份,芦荟7份,仙鹤草14份,巴戟天9份,肉苁蓉6份,佛手10份,荜拨5份,陈皮3份,厚朴8份,马齿苋8份,合欢皮14份,三七4份,地榆9份,桑葚5份。
本发明还涉及一种所述的用于治疗小儿腹泻的中药组合物的制备方法,包括如下步骤:
(1)按照重量组分取芦荟、桑葚外的各药材,加药材总重量的10-12倍的水,浸泡45-60分钟后,煎煮1次,煎煮时间2小时,滤过后,加药材总重量的12-13倍的水,煎煮第2次,煎煮时间3小时,滤过后,加药材总重量的14-15倍的水,煎煮第3次,煎煮时间4小时,滤过后,合并3次滤液,120目滤过,滤液加热浓缩成60℃下相对密度为1.10~1.13的稠膏,备用;
(2)按照重量组分取芦荟,粉碎处理后放入容器内,绞汁,滤杂质,留汁液备用;
(3)按照重量组分取桑椹,洗净后浸入5倍量的80-90%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.25的稠膏,备用;
(4)将步骤(1)—(3)制得的稠膏、汁液混合后干燥,制成胶囊剂。
本发明还涉及一种所述中药组合物在治疗小儿腹泻药物中的应用。
本发明所提供的用于治疗小儿腹泻的中药组合物,其以常见的中草药为原料,充分发挥各组分的药性:
艾叶:性味苦、辛、温,入脾、肝、肾经。能散寒除湿,温经止血。治心腹冷痛,泄泻转筋,久痢,吐衄,下血,月经不调,崩漏,带下,胎动不安,痈疡,疥癣。
乌药:辛,渴。归肺、脾、肾、膀胱经。功效与主治:顺气止痛,温肾散寒。用于胸腹胀痛,气逆喘急,膀胱虚冷,遗尿尿频,疝气,痛经。
吴茱萸,辛、苦,热;有小毒。归肝、脾、胃、肾经。散寒止痛,降逆止呕,助阳止泻。用于厥阴头痛,寒疝腹痛,寒湿脚气,痛经,经行腹痛,脘腹胀痛,呕吐吞酸,五更泄泻,外治口疮;高血压。
穿心莲:味苦,性寒,归心、肺、大肠、膀胱经,具有清热解毒,凉血,消肿,燥湿的功效,主治感冒发热,咽喉肿痛,口舌生疮,顿咳劳嗽,泄泻痢疾,热淋涩痛,痈肿疮疡,毒蛇咬伤等证。
石斛,味甘、性微寒,归胃、肾经。功能主治:益胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明。石斛、麦冬养阴清热、益胃生津。
山药:甘,平。归脾、肺、肾经。功能主治:补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。大枣:甘,温。入脾、胃经。补脾和胃,益气生津,调营卫,解药毒。治胃虚食少,脾弱便溏,气血津液不足,营卫不和,心悸怔忡。妇人赃躁。
豆蔻:辛,温。归肺、脾、胃经。化湿消痞,行气温中,开胃消食。用于湿浊中阻,不思饮食,湿温初起,胸闷不饥,寒湿呕逆,胸腹胀痛,食积不消。
知母:苦、甘,寒。归经:归肺、胃、肾经。功能主治:清热泻火,生津润燥。用于外感热病,高热烦渴,肺热燥咳,骨蒸潮热,内热消渴,肠燥便秘。
葛根:基原:为豆科葛属植物野葛或甘葛藤的块根。成分:野葛根含黄酮类:大豆苷元,大豆苷,葛根素,4’-甲氧基葛根素,大豆苷元-4’,7-二葡萄糖苷,大豆苷元-7-葡萄糖苷等。药性:甘、辛,平。归脾、胃经。功用主治:解肌发表,生津止渴,升阳止泻。主治外感发热,头项强痛,麻疹初起,疹出不畅,温病口渴,消渴病,泄泻,痢疾。
金银花:金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
青黛:又名青蛤粉、靛青花,为爵床科马蓝属植物马蓝、蓼科蓼属植物蓼蓝、豆科木蓝属植物木蓝、十字花科菘蓝属植物菘蓝的叶或茎叶经加工制得的干燥粉末或团块。药性:本品为深蓝色的粉末,体轻,易飞扬,微有草腥气,味咸,性寒。成分:其主要成分有靛玉红,靛蓝。根据现代药理研究发现,该药具有抗肿瘤、抗炎镇痛、抗溃疡、抗菌、清热凉血、解毒的功效,用于温毒斑疹,咽喉肿痛,吐血,衄血,咯血等症状。
藿香,辛,微温。如肺、脾、胃经。功能主治:快气,和中,辟秽,祛湿,治感冒暑湿,寒热,头痛,胸腕痞闷,呕吐泄泻,疟疾,痢疾,口臭。
桂枝味辛甘,性温,是里寒常用的内温药,具有补元阳、通腑降浊、通血脉、暖脾胃之功效,常与补肝肾药、补气血药配伍,治疗肾阳不足、命门火衰、肢冷脉微,与其它温里药配伍治疗脘腹冷痛、寒痹腰痛,具有明显的镇痛和抗癌防癌的作用。
荷叶:味苦,性平;归肝、脾、胃经。清热解暑,升发清阳,凉血止血。用于暑热烦渴,暑湿泄泻,脾虚泄泻,血热吐衄,便血崩漏,降血压,降血脂。现代研究表明,荷叶有降血脂作用。
王不留行:味苦、性平,归胃经,具有活血通经下乳的功效,善于通利血脉,行而不走,走而不守,上能通乳汁,下能通闭经。
木通:用于热淋涩痛,水肿等方面,能利水消肿,下利湿热,使湿热之邪下行从小便排出。在体外对革兰阳性菌及革兰阴性杆菌如痢疾杆菌、伤寒杆菌均有抑制作用。对堇色毛癣菌也有不同程度的抑菌作用。
徐长卿,主治:镇痛,止咳,利水消肿,活血解毒。治胃痛,牙痛,风湿疼痛,经期腹痛,慢性气管炎,腹水,水肿,痢疾,肠炎,跌打损伤,湿疹,荨麻疹,毒蛇咬伤。
川楝子:中药材,为楝科落叶乔木川楝树的成熟果实,性寒,味苦,是行气药的一种。有舒肝行气止痛,驱虫的药效。用于胸胁、脘腹胀痛,疝痛,虫积腹痛。而且还是制作高效无残毒无污染的新型植物性农药的重要原料。川楝子苦寒沉降,主要入肝经,疏泄肝热,行气止痛,治气郁而有热之证尤宜。
芦荟:味苦性寒,清肝热、通便、杀虫;此外还用于头痛、大便秘结、小儿惊痫、疳疡疖肿、烧烫伤、癣疮、痔、萎缩性鼻炎、瘰、肝炎、胆道结石、湿癣等。芦荟的叶片中含有超过二百种化合物,当中包括有20种矿物质、18种氨基酸、12种维生素及其他各种不同的养分,包括多种黏多糖、脂肪酸、蒽醌类及黄酮类化合物、糖、活性酶等。蒽醌类又名安特拉归农综合体,有消毒杀菌的功效,主要存在于汁液里。
仙鹤草,味苦、涩,性平,入肺、肝、脾经,仙鹤草素具有促进血液凝固作用,收缩周围血管,缩短出凝血时间,还能增加血小板数量,具有凉血止血、消痈退肿之功效,用于外伤出血、内脏手术时出血或渗血,还具有抗菌作用,尤其是对金黄色葡萄球菌、大肠杆菌、绿脓杆菌等有较强的抑制作用。
巴戟天,甘,辛,微温。归肾、肝经。功能主治:补肾阳,强筋骨,祛风湿。用于阳痿遗精,宫冷不孕,月经不调,少腹冷痛,风湿痹痛,筋骨痿软。
肉苁蓉,甘、咸,温。归肾、大肠经。补肾阳,益精血,润肠通便。用于阳痿,不孕,腰膝酸软,筋骨无力,肠燥便秘。《本经》:“主五劳七伤,补中,除茎中寒热痛,养五脏,强阴,益精气,妇人症瘕。”
佛手:辛、苦、酸,温;归肝、脾、肺经。《滇南本草》:“补肝暖胃,止呕吐,佛手消胃寒痰,治胃气疼痛,止面寒疼,和中行气。”《本草再新》:“治气舒肝,和胃化痰,破积,治噎膈反胃,消症瘕瘰疬。”舒肝理气,和胃止痛。用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐。
荜拨,味辛,性温,归胃、脾、肾经,具有祛寒、活血、温阳、通痹、理气等功效,主要用于治疗冠心病心绞痛、腹痛、腹泻等疾病。
陈皮性温,味辛、味苦。入脾经、胃经、肺经。理气健脾,调中,燥湿,化痰。主治脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。用于胸脘胀满,食少吐泻,咳嗽痰多。《本草纲目》:其至百并总是取棋理气燥湿之功,同补药则补,同泻药则泻,同升药则升,同降药则降。脾乃元气之母,肺乃摄气之要,故橘皮为二经气分之要,但随所配而补泻升降也。《日用本草》:能散能泻,能温能补,能消膈气,化痰涎,和脾止嗽,通五淋。
厚朴:苦、辛,温。归脾、胃、肺、大肠经。功效与主治:燥湿消痰,下气除满。用于湿滞伤中,脘痞吐泻,食积气滞,腹胀便秘,痰饮喘咳。
马齿苋:酸;性寒。清热解毒;凉血止痢;除湿通淋。主热毒泻痢;热淋;尿闭;赤白带下;崩漏;痔血;疮疡痈疖;丹毒;瘰疬;湿癣;白秃。
合欢皮:味甘,性平。有解郁安神,活血消肿的功效,用于心神不安,解郁失眠,肺痈疮肿,跌扑伤痛。
三七:性温,味甘、微苦,归肝、胃经,具有止血,散瘀,消肿,止痛的作用,主治:治吐血,咳血,衄血,便血,血痢,崩漏,症瘕,产后血晕,恶露不下,跌扑瘀血,外伤出血,痈肿疼痛等证,现代药理证明,三七能够止血、抗血栓、促进造血、抗炎、保肝、抗肿瘤、镇痛、对心血管有良好的作用,对心肌损伤有保护作用。
地榆:药性:苦酸;寒;无毒。归经:肝;肺;肾;大肠经。功效:凉血止血,清热解毒,消肿敛疮。功效分类:止血药;凉血止血药。功用主治:吐血,咯血,衄血,尿血,便血,痔血,血痢,崩漏,赤白带下,疮痈肿痛,湿疹,阴痒,水火烫伤,蛇虫咬伤。
桑葚:甘、酸,寒。归心、肝、肾经。功效与主治:补血滋阴,生津润燥。用于眩晕耳鸣,心悸失眠,须发早白,津伤口渴,内热消渴,血虚便秘。
中医认为泄泻产生的病机关键在于脾虚湿盛,而小儿具有“脾常不足”的生理特点,故临床腹泻患儿以脾虚证常见。《活幼口议·卷十六·议吐泻详证六法所治》曰:“脏腑虚寒,泄泻不止。”《幼幼集成·卷三·泄泻证治》曰:“久泻不止,多属虚寒。”脾胃虚弱尤其是脾阳亏虚是导致小儿腹泻的重要病因,且腹泻日久必致脾虚,两者互为因果,导致腹泻迁延难愈,治疗更加困难,对小儿的健康危害甚大。本发明中药组方中艾叶、木通、马齿苋、穿心莲清热利湿,共为君药;陈皮理气健脾,燥湿化痰,厚朴燥湿消痰,石斛益胃生津,滋阴清热,豆蔻化湿消痞,行气温中,藿香快气和中,辟秽祛湿,徐长卿利水消肿,活血解毒,巴戟天补肾阳,强筋骨,祛风湿,陈皮、厚朴、石斛、豆蔻、藿香、徐长卿、巴戟天共为臣药;乌药、吴茱萸、山药、知母、葛根、金银花等药为佐使,补脾养胃,温肾散寒,助阳止泻,舒肝理气,清热泻火,通腑降浊,补血滋阴。诸药共用,起到清热利湿,健脾燥湿之功,可对小儿腹泻起到良好的治疗效果。
本发明的中药组合物配制简便,药源广泛,成本低廉,其遵循中医的处方用药原则,诸药合用,相得益彰,治疗小儿腹泻方面疗效显著。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合实施例对本发明的技术方案进行清楚、完整地描述。显然,所描述的实施例是本发明的一部分,而不是全部的实施例。基于所描述的本发明的实施例,本领域普通技术人员在无需创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶15克,乌药15克,吴茱萸8克,穿心莲5克,石斛3克,山药14克,豆蔻9克,知母6克,葛根6克,金银花8克,青黛3克,藿香15克,桂枝5克,荷叶3克,王不留行5克,木通12克,徐长卿16克,川楝子3克,芦荟12克,仙鹤草12克,巴戟天10克,肉苁蓉9克,佛手8克,荜拨5克,陈皮1克,厚朴10克,马齿苋5克,合欢皮16克,三七10克,地榆8克,桑葚5克。
其中,所述中药组合物按照下列方法进行制备:
(1)按照重量组分取芦荟、桑葚外的各药材,加药材总重量的10-12倍的水,浸泡45-60分钟后,煎煮1次,煎煮时间2小时,滤过后,加药材总重量的12-13倍的水,煎煮第2次,煎煮时间3小时,滤过后,加药材总重量的14-15倍的水,煎煮第3次,煎煮时间4小时,滤过后,合并3次滤液,120目滤过,滤液加热浓缩成60℃下相对密度为1.10~1.13的稠膏,备用;
(2)按照重量组分取芦荟,粉碎处理后放入容器内,绞汁,滤杂质,留汁液备用;
(3)按照重量组分取桑椹,洗净后浸入5倍量的80-90%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.25的稠膏,备用;
(4)将步骤(1)—(3)制得的稠膏、汁液混合后干燥,制成胶囊剂。
实施例2:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶20克,乌药10克,吴茱萸12克,穿心莲2克,石斛7克,山药11克,豆蔻15克,知母3克,葛根4克,金银花10克,青黛4克,藿香13克,桂枝6克,荷叶4克,王不留行8克,木通20克,徐长卿10克,川楝子8克,芦荟5克,仙鹤草17克,巴戟天12克,肉苁蓉4克,佛手13克,荜拨3克,陈皮3克,厚朴5克,马齿苋10克,合欢皮13克,三七3克,地榆13克,桑葚3克。
制备方法同实施例1。
实施例3:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶18克,乌药11克,吴茱萸9克,穿心莲4克,石斛6克,山药12克,豆蔻13克,知母4克,葛根5克,金银花12克,青黛3克,藿香12克,桂枝9克,荷叶4克,王不留行7克,木通13克,徐长卿11克,川楝子4克,芦荟6克,仙鹤草13克,巴戟天7克,肉苁蓉5克,佛手9克,荜拨4克,陈皮2克,厚朴6克,马齿苋6克,合欢皮14克,三七5克,地榆10克,桑葚4克。
制备方法同实施例1。
实施例4:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶16克,乌药14克,吴茱萸11克,穿心莲3克,石斛5克,山药13克,豆蔻14克,知母5克,葛根4克,金银花11克,青黛4克,藿香14克,桂枝8克,荷叶3克,王不留行6克,木通17克,徐长卿15克,川楝子7克,芦荟11克,仙鹤草16克,巴戟天8克,肉苁蓉8克,佛手12克,荜拨3克,陈皮1克,厚朴10克,马齿苋9克,合欢皮13克,三七7克,地榆11克,桑葚3克。
制备方法同实施例1。
实施例5:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶19克,乌药13克,吴茱萸10克,穿心莲4克,石斛4克,山药11克,豆蔻11克,知母5克,葛根6克,金银花9克,青黛5克,藿香12克,桂枝7克,荷叶5克,王不留行9克,木通15克,徐长卿12克,川楝子5克,芦荟9克,仙鹤草15克,巴戟天9克,肉苁蓉7克,佛手10克,荜拨5克,陈皮3克,厚朴8克,马齿苋8克,合欢皮14克,三七9克,地榆12克,桑葚5克。
制备方法同实施例1。
实施例6:
本发明的一种用于治疗小儿腹泻的中药组合物,取下列中药原料药:艾叶17克,乌药13克,吴茱萸10克,穿心莲4克,石斛4克,山药11克,豆蔻11克,知母5克,葛根3克,金银花8克,青黛5克,藿香15克,桂枝7克,荷叶2克,王不留行4克,木通19克,徐长卿14克,川楝子6克,芦荟7克,仙鹤草14克,巴戟天9克,肉苁蓉6克,佛手10克,荜拨5克,陈皮3克,厚朴8克,马齿苋8克,合欢皮14克,三七4克,地榆9克,桑葚5克。
制备方法同实施例1。
急性毒性试验:
试验动物:小白鼠,体重在50g左右,雌雄随机选择,由市场购买。药物:本发明胶囊剂。
方法:将本发明实施例2胶囊剂50g,分别用150ml温开水调制成溶液,喂食药物溶液,容积2ml/10g体重,密切观察8h并作记录,继续观察7天。
方法和结果:取小白鼠10只,饥饿20小时左右,按每只每天分5次灌喂40ml,连续喂一周,观察10天,小鼠活动正常,无毒性反应,无死亡。表明本发明中药组合物无急性毒性,临床用药剂量安全。
长期毒性实验:
试验动物:大白鼠,体重在120-130g,雌雄随机选择,由市场购买。药物:本发明胶囊剂,将本发明实施例2胶囊剂50g,分别用150ml温开水调制成溶液。方法和结果:取大白鼠20只,分成2组,每组10只,其中第1组作为给药组,按每只每天2次灌喂,每次5-10ml不等,第2组正常喂食作为对照组,每日一次,连续灌喂90天,测体重,于最后一次给药后24小时断头处死,测血、尿常规、肝功能、肾功能,取心、肾等内脏,观察组织形态的变化,观察剂量的作用,观察饮食、活动的变化,实验证明给药组与对照组比较无显著变化,均无毒性反应,是一种安全的药物。
临床论证:
为了验证本发明中药组合物的效果,2013年7月-2014年11月,门诊处随机选择180例小儿腹泻患者,对本发明药物的疗效进行了临床观察。将180例病例随机分为两组,治疗组90例,对照组90例。病例均根据《中医病症诊断疗效标准》的诊断标准,确诊为小儿腹泻。
诊断标准:
(1)大便次数增多,每日3-5次,多达10次以上,呈淡黄色,如蛋花汤样,或色褐而臭,可有少量粘液。或伴有恶心,呕吐,腹痛,发热,口渴等症;
(2)有乳食不节,饮食不洁或感受时邪的病史;
(3)重者腹泻及呕吐较严重者,可见小便短少,体温升高,烦渴神萎,皮肤干瘪,囟门凹陷,目珠下陷,啼哭无泪,口唇樱红,呼吸深长,腹胀等症;
(4)大便镜检可有脂肪球,少量红白细胞;
(5)大便病原体检查可有致病性大肠杆菌等生长,或分离轮状病毒等;
(6)重症腹泻有脱水、酸碱平衡失调及电解质紊乱。
治疗方法:
对照组采用思密达,口服,儿童:1岁以下,每日1袋,分3次服用:1-2岁:每日1-2袋,分3次服用,2岁以上:每日2-3袋,分3次服用。5天为1个疗程,共治疗1~2个疗程。
治疗组将本发明实施例3中胶囊剂,口服即可,每日2次,每次1粒,饭后温开水送服或入水服;5天为1个疗程,1~2个疗程即可痊愈,病情严重者遵医嘱酌增用量。
疗效评定:根据1998年北京全国腹泻防治学术研讨会组织委员会修订的《腹泻病疗效判断标准的补充建议》制定如下疗效评价标准:
治愈:治疗2天内,腹泻次数减少到3次以内,腹泻总量<150ml,3天内粪便形状及次数恢复正常,全身症状消失。
有效:用药2天内,腹泻次数减少到5次以内,腹泻总量<250ml,3天内粪便形状及次数明显好转,全身症状明显改善。
无效:用药2天内,腹泻次数仍在5次以上,腹泻总量>300ml,3天内粪形状、次数及全身症状无明显好转至恶化。
两组病例治疗后疗效比较结果见表1。
表1两组患者有效率对比分析
| 组别 | 例数 | 治愈 | 有效 | 无效 | 总有效 |
| 治疗组 | 90 | 59(65.6%) | 27(30%) | 4(4.4%) | 86(95.6%) |
| 对照组 | 90 | 35(38.9%) | 17(18.9%) | 38(42.2%) | 52(57.8%) |
其中,总有效率=治愈率+显效率。
表1结果显示:服用本发明实施例3的药物制剂总有效率95.6%,而对照组的总有效率只有57.8%;从治愈率也可以看出,本发明实施例1的药物制剂的治愈率远大于对照组。因而本发明药物制剂与现有技术相比有十分显著的优势。
典型病例:
病例1
赵某,男,2岁,青岛市崂山区人。患儿因消化不良,而引起腹泻,每日腹泻数6次不等,用过多种药物治疗,效果很差,治愈无效。后来我院就诊,服用本发明中药制剂治疗,服用1个疗程后,症状明显减轻,服用2个疗程后,症状消失。
病例2
钱某,男,3岁,青岛即墨人。患者腹痛,大便稀,每日5次左右,大便微发绿,带有消化食物残渣,用药5天后效果不佳,来我院就诊。服用本发明中药制剂治疗,服用1个疗程后,症状有所减轻,服用2个疗程后,症状消失,痊愈。
病例3:
孙某,男,4岁,烟台莱阳人。患儿曾经在六月份的时候腹泻,持续多天,是因为积食加着凉,拉的非常严重,还伴有发烧,呕吐,用过几种药物治疗,效果很差。服用本发明中药制剂治疗,服用1个疗程后,症状有所缓解,继续服用1个疗程后,症状消失,痊愈。
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种用于治疗小儿腹泻的中药组合物,其特征在于:所述中药组合物的原料药由艾叶、乌药、吴茱萸、穿心莲、石斛、山药、豆蔻、知母、葛根、金银花、青黛、藿香、桂枝、荷叶、王不留行、木通、徐长卿、川楝子、芦荟、仙鹤草、巴戟天、肉苁蓉、佛手、荜拨、陈皮、厚朴、马齿苋、合欢皮、三七、地榆、桑葚等原料药组成。
2.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶15-20份,乌药10-15份,吴茱萸8-12份,穿心莲2-5份,石斛3-7份,山药11-14份,豆蔻9-15份,知母3-6份,葛根3-6份,金银花8-13份,青黛3-5份,藿香11-15份,桂枝5-10份,荷叶2-5份,王不留行4-9份,木通12-20份,徐长卿10-16份,川楝子3-8份,芦荟5-12份,仙鹤草12-17份,巴戟天7-12份,肉苁蓉4-9份,佛手8-13份,荜拨3-5份,陈皮1-3份,厚朴5-10份,马齿苋5-10份,合欢皮13-16份,三七3-10份,地榆8-13份,桑葚3-5份。
3.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶15份,乌药15份,吴茱萸8份,穿心莲5份,石斛3份,山药14份,豆蔻9份,知母6份,葛根6份,金银花8份,青黛3份,藿香15份,桂枝5份,荷叶3份,王不留行5份,木通12份,徐长卿16份,川楝子3份,芦荟12份,仙鹤草12份,巴戟天10份,肉苁蓉9份,佛手8份,荜拨5份,陈皮1份,厚朴10份,马齿苋5份,合欢皮16份,三七10份,地榆8份,桑葚5份。
4.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶20份,乌药10份,吴茱萸12份,穿心莲2份,石斛7份,山药11份,豆蔻15份,知母3份,葛根4份,金银花10份,青黛4份,藿香13份,桂枝6份,荷叶4份,王不留行8份,木通20份,徐长卿10份,川楝子8份,芦荟5份,仙鹤草17份,巴戟天12份,肉苁蓉4份,佛手13份,荜拨3份,陈皮3份,厚朴5份,马齿苋10份,合欢皮13份,三七3份,地榆13份,桑葚3份。
5.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶18份,乌药11份,吴茱萸9份,穿心莲4份,石斛6份,山药12份,豆蔻13份,知母4份,葛根5份,金银花12份,青黛3份,藿香12份,桂枝9份,荷叶4份,王不留行7份,木通13份,徐长卿11份,川楝子4份,芦荟6份,仙鹤草13份,巴戟天7份,肉苁蓉5份,佛手9份,荜拨4份,陈皮2份,厚朴6份,马齿苋6份,合欢皮14份,三七5份,地榆10份,桑葚4份。
6.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶16份,乌药14份,吴茱萸11份,穿心莲3份,石斛5份,山药13份,豆蔻14份,知母5份,葛根4份,金银花11份,青黛4份,藿香14份,桂枝8份,荷叶3份,王不留行6份,木通17份,徐长卿15份,川楝子7份,芦荟11份,仙鹤草16份,巴戟天8份,肉苁蓉8份,佛手12份,荜拨3份,陈皮1份,厚朴10份,马齿苋9份,合欢皮13份,三七7份,地榆11份,桑葚3份。
7.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶19份,乌药13份,吴茱萸10份,穿心莲4份,石斛4份,山药11份,豆蔻11份,知母5份,葛根6份,金银花9份,青黛5份,藿香12份,桂枝7份,荷叶5份,王不留行9份,木通15份,徐长卿12份,川楝子5份,芦荟9份,仙鹤草15份,巴戟天9份,肉苁蓉7份,佛手10份,荜拨5份,陈皮3份,厚朴8份,马齿苋8份,合欢皮14份,三七9份,地榆12份,桑葚5份。
8.根据权利要求1所述的用于治疗小儿腹泻的中药组合物,其特征在于:制成所述中药组合物的原料组成及重量份数为:艾叶17份,乌药13份,吴茱萸10份,穿心莲4份,石斛4份,山药11份,豆蔻11份,知母5份,葛根3份,金银花8份,青黛5份,藿香15份,桂枝7份,荷叶2份,王不留行4份,木通19份,徐长卿14份,川楝子6份,芦荟7份,仙鹤草14份,巴戟天9份,肉苁蓉6份,佛手10份,荜拨5份,陈皮3份,厚朴8份,马齿苋8份,合欢皮14份,三七4份,地榆9份,桑葚5份。
9.权利要求3-8任一所述的用于治疗小儿腹泻的中药组合物的制备方法,其特征在于,包括如下步骤:
(1)按照重量组分取芦荟、桑葚外的各药材,加药材总重量的10-12倍的水,浸泡45-60分钟后,煎煮1次,煎煮时间2小时,滤过后,加药材总重量的12-13倍的水,煎煮第2次,煎煮时间3小时,滤过后,加药材总重量的14-15倍的水,煎煮第3次,煎煮时间4小时,滤过后,合并3次滤液,120目滤过,滤液加热浓缩成60℃下相对密度为1.10~1.13的稠膏,备用;
(2)按照重量组分取芦荟,粉碎处理后放入容器内,绞汁,滤杂质,留汁液备用;
(3)按照重量组分取桑椹,洗净后浸入5倍量的80-90%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.25的稠膏,备用;
(4)将步骤(1)—(3)制得的稠膏、汁液混合后干燥,制成胶囊剂。
10.如权利要求1-8任一所述的用于治疗小儿腹泻的中药组合物在治疗小儿腹泻药物中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510719192.6A CN105213941A (zh) | 2015-10-30 | 2015-10-30 | 一种用于治疗小儿腹泻的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510719192.6A CN105213941A (zh) | 2015-10-30 | 2015-10-30 | 一种用于治疗小儿腹泻的中药组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105213941A true CN105213941A (zh) | 2016-01-06 |
Family
ID=54983453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510719192.6A Pending CN105213941A (zh) | 2015-10-30 | 2015-10-30 | 一种用于治疗小儿腹泻的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105213941A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105688150A (zh) * | 2016-03-01 | 2016-06-22 | 考玉芹 | 一种治疗小儿腹泻的中药组合物及其制备方法 |
| CN106266987A (zh) * | 2016-09-12 | 2017-01-04 | 叶青 | 一种儿科临床用于小儿腹泻的配方 |
| CN106422068A (zh) * | 2016-08-28 | 2017-02-22 | 臧玉梅 | 一种辅助治疗小儿腹泻的中医磁疗带 |
| CN115553418A (zh) * | 2022-09-29 | 2023-01-03 | 泸州肥儿粉股份有限公司 | 一种用于腹泻调理的辅食及其制备方法 |
| CN116076717A (zh) * | 2023-03-02 | 2023-05-09 | 美益添生物医药(武汉)有限公司 | 一种调节肠道微生物环境的组合物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101745092A (zh) * | 2010-02-09 | 2010-06-23 | 黄美蓉 | 治疗小儿泄泻的中药 |
| CN103816518A (zh) * | 2014-03-10 | 2014-05-28 | 张良洁 | 用于小儿腹泻护理治疗的中药 |
| CN103977328A (zh) * | 2014-06-02 | 2014-08-13 | 宋小梅 | 一种治疗小儿腹泻的中药制剂及制备方法 |
-
2015
- 2015-10-30 CN CN201510719192.6A patent/CN105213941A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101745092A (zh) * | 2010-02-09 | 2010-06-23 | 黄美蓉 | 治疗小儿泄泻的中药 |
| CN103816518A (zh) * | 2014-03-10 | 2014-05-28 | 张良洁 | 用于小儿腹泻护理治疗的中药 |
| CN103977328A (zh) * | 2014-06-02 | 2014-08-13 | 宋小梅 | 一种治疗小儿腹泻的中药制剂及制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 蔡莉君: "查肛健脾法治疗小儿腹泻60例疗效观察", 《中医儿科杂志》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105688150A (zh) * | 2016-03-01 | 2016-06-22 | 考玉芹 | 一种治疗小儿腹泻的中药组合物及其制备方法 |
| CN106422068A (zh) * | 2016-08-28 | 2017-02-22 | 臧玉梅 | 一种辅助治疗小儿腹泻的中医磁疗带 |
| CN106422068B (zh) * | 2016-08-28 | 2019-01-18 | 韩素亮 | 一种辅助治疗小儿腹泻的中医磁疗带 |
| CN106266987A (zh) * | 2016-09-12 | 2017-01-04 | 叶青 | 一种儿科临床用于小儿腹泻的配方 |
| CN115553418A (zh) * | 2022-09-29 | 2023-01-03 | 泸州肥儿粉股份有限公司 | 一种用于腹泻调理的辅食及其制备方法 |
| CN116076717A (zh) * | 2023-03-02 | 2023-05-09 | 美益添生物医药(武汉)有限公司 | 一种调节肠道微生物环境的组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN103463297B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法和用途 | |
| CN103520518B (zh) | 一种治疗慢性非萎缩性胃炎的中药制剂及其制备方法 | |
| CN103536826B (zh) | 一种治疗阴道炎的中药组合物及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN105662996A (zh) | 治疗月经相关性痤疮的中药面膜 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN103041255A (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
| CN105233078A (zh) | 一种用于治疗病毒性肝炎的中药组合物 | |
| CN104906502A (zh) | 一种用于治疗鸡伤热的药物组合物及其制备方法 | |
| CN105056078A (zh) | 一种治疗胃火炽盛牙痛口臭的中药组合物 | |
| CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
| CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
| CN103977279A (zh) | 一种治疗母猪子宫炎的中药添加剂及其制备方法 | |
| CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
| CN104689128A (zh) | 一种治疗血瘀发热型产后发热的药物及其制备方法 | |
| CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
| CN104740403A (zh) | 一种治疗血虚阴亏型复发性口腔溃疡的药物及其制备方法 | |
| CN103656093B (zh) | 用于治疗猪血痢的药物及其制备方法 | |
| CN105055687A (zh) | 一种治疗阑尾炎的药物及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |
|
| RJ01 | Rejection of invention patent application after publication |